Related Experiment Video

Updated: Jun 14, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Targeting the p53-family in cancer and chemosensitivity: triple threat

J Chung1, M S Irwin

  • 1Cell Biology Program, Hospital for Sick Children Research Institute, Toronto, Ontario, M5G 1L7, Canada.

Current Drug Targets
|March 20, 2010
PubMed

Insights

The p53-family proteins (p53, p63, p73) are key in cancer suppression by inducing apoptosis. Targeting these proteins and their variants offers promising anti-cancer drug strategies.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Drug Discovery

Background:

  • The p53-family comprises p53, p63, and p73, sharing structural and functional similarities.
  • These genes produce variants with opposing roles in cancer, but full-length transactivating (TA) members induce apoptosis and suppress tumors.
  • Many anti-cancer agents enhance the anti-proliferative effects of p53 and TAp63/p73.

Purpose of the Study:

  • To review regulatory pathways of p53-family proteins for understanding drug mechanisms.
  • To summarize recent efforts in reactivating p53 in tumors.
  • To discuss the impact of p63 and p73 on drug discovery and their potential as therapeutic targets.

Main Methods:

  • Literature review of p53-family regulatory pathways.
  • Analysis of current research on p53 reactivation strategies.
  • Examination of the role of p63 and p73 in anti-cancer drug development.

Main Results:

  • p53-family proteins are crucial regulators of apoptosis and tumor suppression.
  • Targeting p53-family members is a key mechanism for many anti-cancer therapies.
  • p63 and p73 present novel opportunities as drug targets.

Conclusions:

  • Understanding p53-family regulation is essential for developing targeted cancer therapies.
  • Reactivating p53 and targeting p63/p73 show significant promise for novel anti-cancer treatments.
  • Simultaneously targeting multiple p53-family members may enhance anti-cancer efficacy.

More Related Videos

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...